1. Clinical and functional changes associated with the sustained virological response after treatment of genotype-1 HCV recurrence in liver transplant recipients: Does sofosbuvir differ from peg-interferon based therapy?. (10th February 2016) Authors: Lenci, I.; Milana, M.; Santopaolo, F.; Rossi, P.; Francioso, S.; Masetti, C.; Di Paolo, D.; Cucchiarelli, S.; De Leonardis, F.; Bosa, A.; Angelico, M.; Baiocchi, L. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Decreased alpha-fetoprotein levels in HCV cirrhotic patients after direct-acting antiviral agents therapy. Does this indicate a reduced risk of hepatocellular carcinoma?. Issue 1 (16th February 2017) Authors: De Leonardis, F.; Masetti, C.; Rossi, P.; Di Paolo, D.; Bosa, A.; Milana, M.; Santopaolo, F.; Cucchiarelli, S.; Pecchioli, A.; Francioso, S.; Lenci, I.; Brega, A.; Marianelli, T.; Antenucci, F.; Di Nardi, S.; Baiocchi, L.; Angelico, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗